TickerFactsScreenerDevelopers

INOVIO PHARMACEUTICALS, INC. (INO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $14.12M2009: $30.30M2010: $20.00M2011: $17.35M2012: $5.65M2013: $33.72M2014: $40.54M2015: $57.63M2016: $19.14M2017: $23.79M2018: $23.69M2019: $22.20M2020: $250.73M2021: $71.14M2022: $46.33M2023: $14.31M2024: $65.81M2025: $44.27M$44.27M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$44.27M-32.7%
2024$65.81M+359.9%
2023$14.31M-69.1%
2022$46.33M-34.9%
2021$71.14M-71.6%
2020$250.73M+1029.6%
2019$22.20M-6.3%
2018$23.69M-0.4%
2017$23.79M+24.3%
2016$19.14M-66.8%
2015$57.63M+42.1%
2014$40.54M+20.2%
2013$33.72M+497.2%
2012$5.65M-67.5%
2011$17.35M-13.2%
2010$20.00M-34.0%
2009$30.30M+114.6%
2008$14.12M—